Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights. - Wikidata - awgldk - TriplyDB

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

http://www.wikidata.org/entity/Q33857581

about

Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia.Translational approaches to treatment-induced symptoms in cancer patients.Review of recent studies on interventions for cognitive deficits in patients with cancer.The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning.

P2860

Q26770267-2885862E-50E7-492D-BD1F-6CC4AA665790 Q33679931-F92428A4-527E-43BA-AA35-67A42EB74477 Q35771188-7942B00B-38F5-425B-96A5-415283788412 Q36143029-C63FFFF4-A348-4316-915E-6FC39C298BEB Q37982452-7092396E-21F2-4E1D-943C-712CB9737950 Q39447268-CFD2F635-A05D-44DC-AE45-FC0C538207F3 Q48229486-23D6ED71-EF09-42C7-A980-F8906AEA1774 Q48285033-4E3FB6CA-7EF5-414E-83C5-267BC9344BF0

P2860

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

http://www.wikidata.org/entity/Q33857581

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@ast

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@en

type

label

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@ast

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@en

prefLabel

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@ast

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@en

P1433

Q33857581-B195BA40-46E9-4E85-8000-8669E9946959

P1476

Q33857581-1DA9C474-93AA-4C60-AA27-AD4B9E198EA2

P2093

Q33857581-7B86F01A-3FCC-4F3D-B6DC-2A40AC93784D

Q33857581-E4BE92C3-82BE-4142-B6FC-6BEB4B7D07F0

Q33857581-F578D1AB-69E5-4A07-AB93-203E5977215A

P2860

Q33857581-03024B99-2226-466C-9708-BED28F6E9AC6

Q33857581-0DC205D1-5FBA-4537-B2DD-603D6CFDA8F1

Q33857581-0E5D2EE2-24BA-470F-8E34-07658D7A9D73

Q33857581-0FD8B217-D68B-4A1C-8C88-EDFC31D66266

Q33857581-1749ED6B-6D0B-435C-920C-D4F637C446DE

Q33857581-18EF53B5-FD21-40FC-8184-E233119972D8

Q33857581-1C4A64CD-FD37-4CDD-9539-916E29E71EBA

Q33857581-20320C3F-966A-41C9-B400-766382862407

Q33857581-294861D3-D757-4944-AC9C-C776B4626C71

Q33857581-2B96DAE6-CE7D-4238-A241-BC53952D445E

P304

Q33857581-75E2AFE7-B0BA-41F5-B71A-B0EA08F53B8A

P31

Q33857581-E6D787B0-BE61-4171-8E22-C6EC41E94519

P356

Q33857581-41DC43BC-C6B1-4CDE-9FA5-C6F6F4352988

P433

Q33857581-28309E57-EF28-4FD1-B2C8-BBBF8B558005

P478

Q33857581-82499646-19E7-42E5-9A74-F25C6531895D

P577

Q33857581-46FCCA55-8992-4446-8360-71BC3A1C76A9

P5875

Q33857581-CD4C08ED-00CB-423F-B3B7-2EAFD32161C9

P698

Q33857581-889978A8-ED5B-43B8-96BA-86B7BBFE1C12

P921

Q33857581-85A9E439-18C2-43B0-89C0-0365F81B0B19

Q33857581-D01E9B7B-D6A1-4BCB-BA8F-3B63928A3A84

P356

P1433

Pharmacogenomics

P1476

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.

@en

P2093

Femke E A M Froklage

http://www.w3.org/2001/XMLSchema#string

Jaap C Reijneveld

http://www.w3.org/2001/XMLSchema#string

Jan J Heimans

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.

Multidrug resistance in cancer: role of ATP-dependent transporters

Toxic leukoencephalopathy

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway

Paraplegia following intrathecal methotrexate: report of a case and review of the literature

Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

Central nervous system toxicity from cancer therapies.

P304

379-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.10.197

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50935300

http://www.w3.org/2001/XMLSchema#string

P698

21449677

http://www.w3.org/2001/XMLSchema#string

P921